Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing Weekly

Review of hedge fund launches, closures, trends, regulatory and legal events - week 32

Saturday, August 13, 2011

As August settles in the number of launches has dwindled, although we did hear that Fund Evaluation Group raised $300m for a new fund, and Lyxor Asset Management confirmed a plan to launch a UCITS hedge fund platform during the Opalesque France Roundtable.

Hedge funds assets expanded after investors poured money into the industry ahead of the global market volatility. Leon Cooperman, Chief Executive Officer of New York-based hedge fund Omega Advisors Inc., sold all of his Bank of America Corp. and Citigroup Inc., shares.

Hedge funds rebounded in July and outperformed global markets by +3.21% after finishing the month up +2.52%YTD. Galloway Global Emerging Markets Fixed Income Fund delivered +2.14% returns in July (+7.00% YTD). K2 Asset Management (KAM) has recorded an after-tax profit of $15.4 million for the 2011 financial year. Mark Spitznagel's hedge fund Universa was up 20%-25% this year.

The market rout last week saw mixed performances as big names like Brevan Howard, Man Group's AHL and Winton managed to make money. Also profiting from the worst route in the equity markets since 2008 were Vulpes Investment Management, Ballingal Investment Advisors Ltd., Riley Paterson Investment Management, and Och-Ziff Capital Management Group LLC.

Other hedge funds felt the crunch of the market volatility and lost money. Most hedge funds are struggling from the extreme sell-off in financials, said Troy Gayeski, senior ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for